Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Theramex Ireland Limited, 3rd Floor, Kilmore House, Park Lane, Spencer Dock, Dublin 1, D01 YE64, Ireland
FemSeven 50,
50 micrograms/24 hours,
Transdermal patch.
| Pharmaceutical Form |
|---|
|
Transdermal patch. Octagonal, transparent, flexible, rounded-edge transdermal matrix patch located on an oversized removable protective liner. |
Each patch contains 1.5 mg of estradiol hemihydrate in a patch size of 15 cm², releasing 50 micrograms of estradiol per 24 hours.
For the full list of excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Estradiol |
Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. |
| List of Excipients |
|---|
|
Backing layer: Transparent polyethylene terephthalate (PET) foil. Adhesive matrix: Styrene-isoprene block copolymer, glycerine esters of completely hydrogenated resins. |
The container (primary packaging) consists of a sealed laminated sachet. This comprises layers of food grade paper/polyethylene/aluminium/ethylene copolymer.
Package sizes: Carton of 4 and 12 patches.
Theramex Ireland Limited, 3rd Floor, Kilmore House, Park Lane, Spencer Dock, Dublin 1, D01 YE64, Ireland
PL 49876/0007
14/12/2005 / 14/12/2010
| Drug | Countries | |
|---|---|---|
| FEMSEVEN | Austria, Italy, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
